Cargando…
NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling
SIMPLE SUMMARY: G protein–coupled receptors (GPCRs) are the most critical protein group for drug development, targeting about 35% of approved drugs. As their abnormal activation causes many diseases, including cancer, it is beneficial to discover novel GPCRs that are aberrantly expressed in cancer a...
Autores principales: | Shin, Yuna, Jung, Wonhee, Kim, Mi-Yeon, Shin, Dongjo, Kim, Geun Hee, Kim, Chun Ho, Park, Sun-Hoo, Cho, Eung-Ho, Choi, Dong Wook, Han, Chul Ju, Lee, Kee Ho, Kim, Sang-Bum, Shin, Hyun Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737590/ https://www.ncbi.nlm.nih.gov/pubmed/36497331 http://dx.doi.org/10.3390/cancers14235850 |
Ejemplares similares
-
The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma
por: Lee, Myung-Jin, et al.
Publicado: (2022) -
The Short-Chain Fatty Acid Receptor GPR43 Modulates YAP/TAZ via RhoA
por: Park, Bi-Oh, et al.
Publicado: (2021) -
Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts
por: Kim, Do Kyeong, et al.
Publicado: (2019) -
Regulation of RhoA activity by the cellular prion protein
por: Kim, Hee-Jun, et al.
Publicado: (2017) -
Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma
por: Choi, Jung-il, et al.
Publicado: (2017)